Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 10,533 shares at $40.29 ($424K) on 2021-04-15, disclosed to the SEC on 2021-04-19.
Open-market sale of $424k KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.29 | 4,940 | $199K | 46.9% |
| 2 | $40.29 | 4,940 | $199K | 46.9% |
| 3 | $40.00 | 653 | $26K | 6.2% |
| Total | $40.27 avg | 10,533 | $424K | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |